MCMedicalCodingSoftware
C69.50

C69.50: Malignant neoplasm of unspecified lacrimal gland and duct

Billable / specific codeICD-10-CM

C69.50 is a billable, specific ICD-10-CM code for malignant neoplasm of unspecified lacrimal gland and duct. It is valid for submission on a claim.

Check C69.50 with the rest of the claim: free scrubber

Excludes1 inherited from the categories above C69.50

A category’s note binds every code beneath it.

Written on C69: Malignant neoplasm of eye and adnexa

  • malignant neoplasm of connective tissue of eyelid (C49.0)
  • malignant neoplasm of eyelid (skin) (C43.1-, C44.1-)
  • malignant neoplasm of optic nerve (C72.3-)

Risk adjustment

C69.50 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

  • HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C69.50 is named in 34 Medicare coverage policies: 34 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A55717Billing and Coding: Lab: Flow Cytometry
  • A56748Billing and Coding: White Cell Colony Stimulating Factors
  • A56827Billing and Coding: Proton Beam Therapy
  • A56867Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under C69.5

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.